Net Income (Loss) Per Share (Tables)

3 Months Ended

Mar. 31, 2025

Schedule of Reconciliation of the Numerator and Denominator Used in the Calculation of Basic and Diluted Net Income (Loss) Per Share

A reconciliation of the numerator and denominator used in the calculation of basic and diluted net loss per share of Class A common stock is as follows:


	Three months ended Mar. 31,
(in thousands, except per share amounts)	2025		2024
Numerator:
Net loss	$	(9,786)	$	(21,346)
Less: Net loss attributable to non-controlling interests	(5,378)		(12,130)
Net loss attributable to GoHealth, Inc.	(4,408)		(9,216)
Less: Dividends accumulated on redeemable convertible preferred stock	956		892
Net loss attributable to common stockholders - basic and diluted	(5,364)		(10,108)




Denominator:
Weighted-average shares of Class A common stock outstanding—basic and diluted	10,373		9,715





Net loss per share of Class A common stock—basic and dilutive	$	(0.52)	$	(1.04)

Schedule of Antidilutive Securities Excluded From Calculation of Diluted Income (Loss) Per Share

The following number of shares were excluded from the calculation of diluted loss per share of Class A common stock because the effect of including such potentially dilutive shares would have been antidilutive:


	Mar. 31,
(in thousands)	2025	2024
Equity awards	2,307	1,671
Redeemable convertible preferred stock	4,113	3,989
Class B common stock	12,623	12,783